Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Raised to $61 at Piper Jaffray
-
-
-
-
-
-
-
Acadia Pharma (ACAD) Prices 6.06M Common Stock Offering at $33/Share
-
-
-
-
-
-
-
Streetinsider.com's Hot Lunchtime Reads 5/2: (AAPL) (COH) (ACAD) (GPL)
-
-
-
-
-
-
-
Piper Jaffray Upgrades Acadia Pharmaceuticals (ACAD) to Overweight
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Cut to $39 at Piper Jaffray; 'Overweight' Maintained
-
-
-
-
-
-
-
ACADIA Pharmaceuticals (ACAD) Shares Rise Sharply on Pimavanserin Update
-
-
-
20,799 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
